Disclosures / Herzberg, Dr. Max
T9G
Vidac Pharma Holding PLC
Amount
€12K
@ €0.60 / per share
Detailed Analysis
Dr. Max Herzberg, a Management Board member at Vidac Pharma Holding PLC, sold €12,000 worth of shares at €0.60 per share on April 27, 2026. This open-market sale carries limited analytical weight since such transactions can reflect routine portfolio rebalancing rather than conviction about valuation. The 7-day disclosure delay is compliant with MAR regulations and provides no incremental signal regarding the transaction's rationale.
Price history — T9G
Price since trade
—
SPY since trade
—
No price data available
Trade date
27 April 2026
When the trade occurred
Disclosed date
04 May 2026
7-day delay
Disclosure delay: 7 days. This trade was reported to regulators 7 days after it occurred. By the time this filing became public, markets had 7 additional days to react to any non-public information.
Reference data
Use these identifiers to look up this instrument in your own platform. Disclosyr does not link to any broker.
Ticker
T9G
ISIN
GB00BM9XQ619
Exchange
XETR
Company
Vidac Pharma Holding PLC
Filed with bafin germany on 04 May 2026